HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.

3rd Edition of International Conference on Gastroenterology

September 27-29, 2027 London, UK

September 27 -29, 2027 | London, UK

Gastrointestinal Pharmacotherapy and Drugs

Gastrointestinal Pharmacotherapy and Drugs

Pharmacotherapy differs from surgery (surgical therapy), radiation (radiation therapy), movement (physical therapy), and other types of treatment in that it uses pharmaceutical drugs. Pharmacotherapy is occasionally used by professionals to refer to medication rather than surgery or other forms of treatment. The treatment of hepatitis C virus (HCV), irritable bowel syndrome, gastroesophageal reflux disease (GERD), and peptic ulcer disease are just a few of the central issues in gastrointestinal pharmacotherapy that are rapidly evolving. For individuals with moderate to severe irritable bowel syndrome symptoms, pharmacotherapy is currently the first-line treatment. A gastrointestinal drug is a drug that has effects on the gastrointestinal tract, such as reducing gastric acidity, regulating gastrointestinal motility and water flow, and enhancing digestion.

  • Evidence-based Medicine
  • Precision Medicine
  • commonly used gastrointestinal drugs
  • toxicity of drugs
Committee Members
Speaker at GI Conferences - Alberto Maringhini

Alberto Maringhini

La Maddalena Hospital, Italy
Speaker at Gastroenterology Conference - Jose Luis Braga De Aquino

Jose Luis Braga De Aquino

Pontifical Catholic University of Campinas, Brazil
Speaker at Gastroenterology Conferences - Pubali Dhar

Pubali Dhar

University of Calcutta, India

Submit your abstract Today

Watsapp